Eugia Pharma Gets FDA Approval for Pazopanib Tablets
Aurobindo Pharma has announced that its wholly owned subsidiary company, Eugia Pharma Specialities, has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Pazopanib Tablets, 200 mg.
Eugia Pharma Specialities | 06/12/2024 | By Aishwarya
Aurobindo's subsidiary Eugia Pharma Specialities receives final approval from US FDA
Aurobindo's subsidiary Eugia Pharma Specialities receives final approval from US FDA to manufacture, market cancer drug Lenalidomide caps
Eugia Pharma Specialities | 11/03/2023 | By Sudeep Soparkar | 760
Aurobindo Pharma's arm Eugia Pharma Specialities bags
This is a partnership product from TTY Biopharm Company and will be manufactured at the Taiwan facility
Eugia Pharma Specialities | 18/11/2022 | By Sudeep Soparkar | 469
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy